General Anesthesia
When selecting anesthetic agents for pregnant patients undergoing non-obstetric surgery, the choice of induction agents, maintenance agents, and neuromuscular blockers requires careful consideration to balance maternal safety and fetal protection. The choice of induction agents in pregnant patients is crucial to minimize potential fetal risks while providing rapid and smooth induction of anesthesia. Propofol is increasingly used as an induction agent due to its favorable safety profile. It is not teratogenic in animal studies and does not appear to decrease the concentration required for the loss of consciousness in early pregnancy. Propofol also has a rapid onset and short duration of action, which can facilitate smoother emergence and reduce fetal exposure to anesthetic agents. Thiopental was long the standard induction agent for rapid-sequence induction in pregnancy because of its rapid onset, and it is still used where available (it has not been marketed in the United States since 2011); pregnant patients need a lower dose because of increased sensitivity. For the hypovolemic trauma patient, etomidate or ketamine preserves maternal pressure, remembering that ketamine raises uterine tone in early pregnancy at larger doses (above about 1 to 1.5 mg/kg).
Maintenance of anesthesia in pregnant patients can be achieved with a combination of volatile anesthetics and opioids. Volatile anesthetics, such as sevoflurane, isoflurane, and desflurane, are widely used due to their ability to maintain adequate anesthesia depth and provide uterine relaxation. However, it is important to note that the minimum alveolar concentration (MAC) for these agents is reduced by roughly 30% in pregnancy (progesterone and endorphin effects), necessitating careful titration to avoid excessive doses that could lead to hypotension, reduced uteroplacental perfusion, and fetal hypoxia. Volatile agents are uterine vasodilators, and at concentrations up to about 1.5 MAC uterine blood flow is largely maintained; above that, maternal arterial pressure and cardiac output fall and uteroplacental perfusion falls with them. The same agents relax the myometrium, which can be useful when uterine irritability is a concern. Nitrous oxide is generally avoided during the first trimester due to concerns about its potential teratogenicity, particularly at high concentrations; the concern rests on methionine synthase inhibition and prolonged high-dose animal exposures, and no human teratogenic effect has been shown. More broadly, no anesthetic agent in standard concentrations has been shown to be teratogenic in humans at any gestational age (ACOG 2019), and the FDA's 2016 warning about anesthetic neurotoxicity concerns repeated or prolonged exposures (more than 3 hours) in the third trimester rather than a single procedure of ordinary length.
Opioids, such as fentanyl and remifentanil, are also commonly used to provide analgesia and reduce the requirement for volatile agents. However, they are highly lipid-soluble and readily cross the placenta, potentially leading to fetal respiratory depression or withdrawal symptoms with prolonged use. Therefore, opioids should be used judiciously, and brief exposure is generally considered safe. Neuromuscular blocking agents, such as rocuronium and succinylcholine, are often used to facilitate tracheal intubation and muscle relaxation during surgery. These agents have minimal placental transfer due to their ionized nature. However, plasma cholinesterase levels can be reduced by up to 35% in pregnancy, affecting the metabolism of succinylcholine and potentially prolonging its action. Rocuronium with sugammadex is the rapid-sequence alternative when succinylcholine is contraindicated, but the Society for Obstetric Anesthesia and Perinatology (2019) advises against routine sugammadex in pregnant patients because it binds progesterone in vitro and safety data in pregnancy are limited; neostigmine with glycopyrrolate remains the usual reversal, with sugammadex reserved for rescue, such as a cannot-intubate, cannot-oxygenate situation.
| Agent or class | Consideration in the pregnant patient |
|---|---|
| Propofol | Favorable safety profile, not teratogenic in animal studies; rapid onset and short duration ease emergence and limit fetal exposure |
| Thiopental | Historical standard for rapid-sequence induction, still used where available (not marketed in the US since 2011); a lower dose is needed given increased sensitivity |
| Etomidate or ketamine | Preserve maternal pressure in the hypovolemic patient; ketamine raises uterine tone in early pregnancy at doses above about 1 to 1.5 mg/kg |
| Volatile agents (sevoflurane, isoflurane, desflurane) | Provide uterine relaxation; MAC is reduced by roughly 30%. Up to about 1.5 MAC uterine blood flow is largely maintained; higher concentrations reduce maternal arterial pressure and cardiac output, and uteroplacental perfusion falls with them |
| Nitrous oxide | Generally avoided in the first trimester over concerns about teratogenicity at high concentrations |
| Opioids (fentanyl, remifentanil) | Reduce volatile requirement but are highly lipid soluble and cross the placenta; brief exposure is generally considered safe |
| Succinylcholine | Minimal placental transfer, but plasma cholinesterase falls by up to 35%, which may prolong its action |
| Rocuronium and sugammadex | Rocuronium transfers minimally because it is ionized; SOAP 2019 advises against routine sugammadex in pregnancy (binds progesterone in vitro, limited safety data), reserving it for rescue and using neostigmine with glycopyrrolate otherwise |
Regional Anesthesia
Regional anesthesia is often preferred in pregnant patients when feasible, as it allows the mother to maintain her airway, minimizes fetal drug exposure, and provides effective postoperative analgesia. Common regional techniques include spinal anesthesia, epidural anesthesia, and nerve blocks. Spinal anesthesia involves the injection of a local anesthetic into the subarachnoid space and is commonly used for procedures requiring a rapid onset of dense sensory and motor block. Epidural anesthesia involves the injection of a local anesthetic into the epidural space, allowing for continuous or intermittent dosing, making it ideal for longer or more complex surgeries. Nerve blocks are used for targeted analgesia in specific areas and are particularly useful for minor surgeries or as adjuncts to other forms of anesthesia.
Regional anesthesia offers several benefits, including reduced maternal exposure to systemic anesthetic agents, decreased risk of aspiration, and maintenance of consciousness, which facilitates communication and cooperation during surgery. It also allows for better postoperative pain management, as regional techniques provide prolonged analgesia. However, there are limitations to regional anesthesia in pregnant patients, such as the potential for hypotension due to sympathetic blockade, particularly in the setting of pre-existing hypovolemia. This requires careful management with intravenous fluids, vasopressors like phenylephrine, and positioning strategies to maintain adequate uteroplacental perfusion. Additionally, obesity and edema in pregnancy can obscure anatomical landmarks, complicating the placement of epidural or spinal catheters.
Local Anesthesia
Local anesthetics are often used in minor surgeries or as adjuncts to regional or general anesthesia to provide additional analgesia. Lidocaine and bupivacaine are commonly used local anesthetics that are considered safe in pregnancy when used in appropriate doses. However, pregnant patients have an increased sensitivity to local anesthetic agents due to hormonal changes and reduced plasma protein binding, which increases the risk of local anesthetic systemic toxicity (LAST). Lower doses may be required, particularly for neuraxial blocks, where engorged epidural veins shrink the epidural and subarachnoid spaces and spread is wider for a given dose; local anesthetic requirements fall by roughly 25% to 30% from the first trimester onward, so maximum doses are weight-based ceilings, not targets.
In the app: the Master Anesthesia app's Local Anesthetic calculator (Calculators, then Local) computes maximum safe doses of the common agents from the patient's weight and dosing-weight basis, with and without epinephrine, and flags the thresholds where local anesthetic systemic toxicity becomes a concern; in pregnancy, treat the result as an upper limit and dose toward the low end.
Local anesthetics are particularly useful for minor surgical procedures, such as skin excisions, dental procedures, or perineal repairs, where regional or general anesthesia may not be necessary. They are also frequently used as adjuncts to regional anesthesia to enhance the quality of the block or provide additional pain relief in combination with general anesthesia. For example, infiltration of local anesthetics at the surgical site can reduce the requirement for systemic analgesics and improve postoperative pain control. Careful dosing and monitoring for signs of toxicity are essential when using local anesthetics in pregnant patients.
